Acadia Pharmaceuticals ACAD Work in process
Work in process at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryForLongTermContractsOrPrograms.
The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Acadia Pharmaceuticals's work in process.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Acadia Pharmaceuticals's work in process?
- Acadia Pharmaceuticals (ACAD) reported work in process of $80.72M in Q1 2026.
- How has Acadia Pharmaceuticals's work in process changed year-over-year?
- Acadia Pharmaceuticals's work in process increased by 0.9% year-over-year, from $80.03M to $80.72M.
- What is the long-term trend for Acadia Pharmaceuticals's work in process?
- Over 4 years (2021 to 2025), Acadia Pharmaceuticals's work in process has grown at a 87.4% compound annual growth rate (CAGR), from $6.22M to $76.7M.
- What does work in process mean?
- Partially completed goods currently in the manufacturing process, including materials, labor, and overhead costs incurred to date.